OR4F17

Across TCGA pan-cancer cohorts, OR4F17 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR4F17 data layer compared with 1 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR4F17 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4F17 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

COAD, SKCM, and ACC are the cancer types where OR4F17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	III,IV	0.175	0.673	<.001	111	view →
SKCM	OS	Tertile	All	0.179	0.877	<.001	75	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
LUAD	DFS	Tertile	III,IV	0.036	0.673	<.001	18	view →
KIRP	OS	Tertile	II,III,IV	0.610	0.857	.041	9	view →
HNSC	DFS	Tertile	All	1.000	0.308	.028	6	view →
UCEC	OS	Tertile	All	0.793	0.928	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR4F17–COAD (DFS)

Open the COAD breakdown →